Cancer has one the highest mortality rates of all diseases and new treatments are eagerly awaited around the world. Otsuka is committed to delivering new oncology therapies and diagnostics.

Otsuka Pharmaceutical established the (presently named) Fujii Memorial Research Institute in Japan in 1983 to engage in anti-cancer drug research.

Member companies of the Otsuka Group have pipeline products and research programs in areas including breast, colon, gastric, lung and pancreatic cancers as well as for hematologic malignancies.